| Item Type | Name |
|
Concept
|
Leucovorin
|
|
Academic Article
|
Methotrexate: an effective agent for treating cancer and building careers. The polyglutamate era.
|
|
Academic Article
|
Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.
|
|
Academic Article
|
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
|
|
Academic Article
|
Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.
|
|
Academic Article
|
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
|
|
Academic Article
|
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer.
|
|
Academic Article
|
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
|
|
Academic Article
|
Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study.
|
|
Academic Article
|
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.
|
|
Academic Article
|
Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.
|
|
Academic Article
|
Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?
|
|
Academic Article
|
Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
|
|
Academic Article
|
First-line treatment options for patients with metastatic colorectal cancer.
|
|
Academic Article
|
Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.
|
|
Academic Article
|
Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography.
|
|
Academic Article
|
Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
|
|
Academic Article
|
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
|
|
Academic Article
|
Molecular markers to individualize adjuvant therapy for colon cancer.
|
|
Academic Article
|
High-dose methotrexate: a critical reappraisal.
|
|
Academic Article
|
Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study.
|
|
Academic Article
|
Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.
|
|
Academic Article
|
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.
|
|
Academic Article
|
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
|
|
Academic Article
|
Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.
|
|
Academic Article
|
A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients.
|
|
Academic Article
|
Phase I and pharmacokinetic study of 24-hour infusion 5-fluorouracil and leucovorin in patients with organ dysfunction.
|
|
Academic Article
|
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.
|
|
Academic Article
|
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
|
|
Academic Article
|
Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion.
|
|
Academic Article
|
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
|
|
Grant
|
CANCER AND LEUKEMIA GROUP B--PET COMMITTEE
|
|
Grant
|
CELLULAR PHARMACOLOGY OF THE STEREOISOMERS OF LEUCOVORIN
|